|
Kabra Drugs Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
46.09 Cr.
|
P/BV
|
1.87
|
Book Value (Rs.)
|
10.40
|
|
52 Week High/Low (Rs.)
|
23/10
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| | | | | | |
| Other Income | 0.64 | 0.00 | 0.01 | 0.00 | 0.00 |
| Total Revenue | 0.64 | 0.00 | 0.01 | 0.00 | 0.00 |
| | | | | | |
| EXPENSES | | | | | |
| Employee Benefit Expenses | 0.69 | 0.40 | 0.23 | 0.09 | 0.05 |
| Depreciation And Amortisation Expenses | 0.01 | 0.00 | 0.00 | 0.01 | 0.03 |
| Other Expenses | 1.03 | 0.34 | 0.11 | 0.09 | 0.10 |
| Total Expenses | 1.73 | 0.74 | 0.34 | 0.19 | 0.18 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| | | | | | |
| Profit/Loss Before Tax | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Profit/Loss After Tax And Before ExtraOrdinary Items | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| | | | | | |
| Profit/Loss From Continuing Operations | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| | | | | | |
| Profit/Loss For The Period | -1.09 | -0.74 | -0.34 | -0.19 | -0.18 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | -0.99 | -1.66 | -0.77 | -0.42 | -0.41 |
| Diluted EPS (Rs.) | -0.99 | -1.66 | -0.77 | -0.42 | -0.41 |
